Abstract
The General Court of the EU has confirmed a previous decision of the EU Intellectual Property Office (EUIPO) rejecting an opposition against the registration of a composite EU trademark for a drug filed by a proprietor of earlier signs. The later mark was composed by a combination of word and figurative elements. Concurring with the EUIPO, the Court identified in the word element the distinctive dominant element of the later sought mark and ruled that the conflicting marks were not confusingly similar in spite of the common figurative elements they had in common. These figurative elements, indeed, constituted a common feature in the pharmaceutical sector.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
